Expression patterns were highly variable: high SP140 expression was linked to poor prognosis in ccRCC, glioma, LSCC, ovarian and cervical cancers but associated with better prognosis in AML, osteosarcoma, HNSCC, lung cancer, and metastatic melanoma. Here, SP140 is linked to acute myeloid leukemia.